Kevin Mannix | Head, Global IR & VP |
Kare Schultz | President, CEO |
Michael McClellan | EVP & CFO |
Brendan O'Grady | EVP, North America Commercial |
Jason Gerberry | Bank of America Merrill Lynch |
David Maris | Wells Fargo Securities |
Louise Chen | Cantor Fitzgerald & Co. |
Gregory Gilbert | Deutsche Bank |
Christopher Schott | JPMorgan Chase & Co. |
Randall Stanicky | RBC Capital Markets |
Vamil Divan | Crédit Suisse |
David Amsellem | Piper Jaffray Companies |
Kenneth Cacciatore | Cowen and Company |
David Risinger | Morgan Stanley |
Aaron Gal | Sanford C. Bernstein & Co. |
Liav Abraham | Citigroup |
Esther Rajavelu | Oppenheimer |
Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to today's Teva Pharmaceutical Industries Limited Fourth Quarter 2018 Results Conference Call. [Operator Instructions]. I must remind you that this conference is being recorded today, Wednesday, the 13th of February, 2019. And I would now like to hand the conference over to your first speaker today, Mr.